Home > Healthcare > Medical Services > Cell & Gene Therapy Clinical Trial Services Market
Cell & Gene Therapy Clinical Trial Services Market Trends
- Report ID: GMI9355
- Published Date: May 2024
- Report Format: PDF
Cell and Gene Therapy Clinical Trial Services Market Trends
The rapid pace of technological advancement in cell and gene therapy is a catalyst for the growth of the market. These advancements not only enhance the efficacy of treatments but also expand the therapeutic applications of cell and gene therapy across a wide range of diseases that is anticipated to boost the growth of the market.
- For instance, in April 2022, Labcorp a leading global life sciences company collaborated with Xcell Biosciences, Inc, a leading developer of cell and gene therapy technologies, to advance critical work that helps clients effectively bring innovative cell and gene therapies to market. Through this collaboration, LabCorp and Xcellbio work on a series of projects focused on improving the safety and efficacy of cell and gene therapies (CGTs). Thus, the demand for high-quality clinical trial services is expected to grow in tandem, ensuring the safe and effective translation of these innovative therapies from the laboratory to the hospitals & clinic, is anticipated to boost the growth of the market.
Frequently Asked Questions (FAQ) :
The cell and gene therapy clinical trial services market was valued at USD 4 billion in 2023 and will record 10.8% CAGR from 2024-2032, owing to the growing prevalence of chronic and genetic diseases.
The cell therapy segment in the market is expected to reach USD 4.2 billion by end of 2032, due to the improvements in cell manufacturing techniques, such as automation and scale-up capabilities.
U.S. cell & gene therapy clinical trial services market size is expected to exhibit 11% CAGR between 2024 – 2032, owing to the presence of robust biopharmaceutical industry.
ADVARRA, Charles River Laboratories International Inc., Catalent Pharma, ICON PLC, IQVIA, Medpace, Inc., Novotech, Precision Medicine Group, LLC, Parexel International, Syneos Health, Sharp Services, LLC, Thermo Fisher Scientific Inc. and Worldwide Clinical Trials
Cell & Gene Therapy Clinical Trial Services Market Scope
×
Get a free sample of
Cell & Gene Therapy Clinical Trial Services Market
Inquiry Before Buying
Get special pricing options on this report
Request Sectional Data
Over 70% of our clients customize reports to fit their needs. Please tell us how you would like to customize yours
below